⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

Official Title: Phase III Study of Doxorubicin/Cyclophosphamide (AC) Followed by Ixabepilone vs. AC Followed by Paclitaxel in Patients With Triple-Negative Early-Stage Breast Cancer

Study ID: NCT00789581

Conditions

Breast Cancer

Study Description

Brief Summary: This is a randomized, Phase III, open-label, multicenter study.

Detailed Description: Patients will be randomized in a 1:1 ratio to receive one of two different treatment arms. Patients in treatment arm 1 will receive AC followed by ixabepilone. Patients in treatment arm 2 will receive AC followed by weekly paclitaxel.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Northeast Alabama Regional Medical Center, Anniston, Alabama, United States

Cancer Center of Huntsville, Huntsville, Alabama, United States

Clearview Cancer Institute, Huntsville, Alabama, United States

University of Southern Alabama, Mobile, Alabama, United States

Northeast Arkansas Clinic, Jonesboro, Arkansas, United States

Wilshire Oncology Medical Group, La Verne, California, United States

New Hope Cancer and Research Institute, Pomona, California, United States

Eastern Connecticut Hematology Oncology, Norwich, Connecticut, United States

Aventura Medical Center, Aventura, Florida, United States

Lynn Cancer Institute, Boca Raton, Florida, United States

Florida Cancer Care, Davie, Florida, United States

Holy Cross Hospital, Fort Lauderdale, Florida, United States

Florida Cancer Specialists, Fort Myers, Florida, United States

Memorial Regional Cancer Center, Hollywood, Florida, United States

Integrated Community Oncology Network, Jacksonville, Florida, United States

Watson Clinic Center for Cancer Care and Research, Lakeland, Florida, United States

Space Coast Medical Associates, Titusville, Florida, United States

Piedmont Healthcare, Atlanta, Georgia, United States

Emory/Winship Cancer Institute, Atlanta, Georgia, United States

Augusta Oncology Associates, Augusta, Georgia, United States

Medical Oncology Associates of Augusta, Augusta, Georgia, United States

Medical College of Georgia Cancer Specialists, Augusta, Georgia, United States

Northeast Georgia Medical Center, Gainesville, Georgia, United States

Suburban Hem Onc, Lawrenceville, Georgia, United States

Mid-Illinois Hematology & Oncology, Normal, Illinois, United States

Hematology Oncology of the North Shore, Skokie, Illinois, United States

Oncology Hematology Associates of SW Indiana, Evansville, Indiana, United States

Hematology Oncology of Indiana, Indianapolis, Indiana, United States

Providence Medical Group, Terre Haute, Indiana, United States

Kansas City Cancer Centers, Overland Park, Kansas, United States

Cotton O'Neil Cancer Center, Topeka, Kansas, United States

Consultants in Blood Disorders and Cancer, Louisville, Kentucky, United States

Baton Rouge General Medical Center, Baton Rouge, Louisiana, United States

Mercy Hospital, Portland, Maine, United States

Weinberg Cancer Institute at Franklin Square, Baltimore, Maryland, United States

Center for Cancer and Blood Disorders, Bethesda, Maryland, United States

Fallon Clinic, Worcester, Massachusetts, United States

Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States

Fairview Medical Oncology Clinic, Edina, Minnesota, United States

St. Louis Cancer Care, Chesterfield, Missouri, United States

Research Medical Center, Kansas City, Missouri, United States

St. John's Clinic, Springfield, Missouri, United States

Methodist Cancer Center, Omaha, Nebraska, United States

St. Clare's Hospital Oncology and Hematology, Denville, New Jersey, United States

Hematology Oncology Associates of Northern NJ, Morristown, New Jersey, United States

Southern Oncology and Hematology, Vineland, New Jersey, United States

New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States

Alamance Regional Medical Center, Burlington, North Carolina, United States

Oncology Hematology Care, Cincinnati, Ohio, United States

Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center, Columbus, Ohio, United States

Hematology/Oncology Inc, Elyria, Ohio, United States

Hickman Cancer Center (Flower Hospital), Sylvania, Ohio, United States

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

Bux-Mont Oncology, Fox Chase Cancer Center, Rockledge, Pennsylvania, United States

Medical University of South Carolina, Charleston, South Carolina, United States

South Carolina Oncology Associates, PA, Columbia, South Carolina, United States

Lowcountry Hematology Oncology, Mount Pleasant, South Carolina, United States

Coastal Cancer Center, Myrtle Beach, South Carolina, United States

Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States

Associates in Hematology Oncology, Chattanooga, Tennessee, United States

Chattanooga Oncology Hematology Associates, Chattanooga, Tennessee, United States

Family Cancer Center, Collierville, Tennessee, United States

Tennessee Oncology, PLLC, Nashville, Tennessee, United States

Coastal Bend Cancer Center, Corpus Christi, Texas, United States

Center for Cancer and Blood Disorders, Fort Worth, Texas, United States

Medical Oncology Methodist Hospital, Houston, Texas, United States

South Texas Oncology and Hematology, San Antonio, Texas, United States

Peninsula Cancer Institute, Newport News, Virginia, United States

Virginia Cancer Institute, Richmond, Virginia, United States

San Juan Hospital, San Juan, , Puerto Rico

Contact Details

Name: Denise A Yardley, M.D.

Affiliation: SCRI Development Innovations, LLC

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: